Search hospitals

>

California

>

Orange

UC Irvine Health/Chao Family Comprehensive Cancer Center

Claim this profile

Orange, California 92868

Global Leader in Breast Cancer

Global Leader in Ovarian Cancer

Conducts research for Cancer

Conducts research for Lung Cancer

Conducts research for Pancreatic Cancer

519 reported clinical trials

47 medical researchers

Photo of UC Irvine Health/Chao Family Comprehensive Cancer Center in OrangePhoto of UC Irvine Health/Chao Family Comprehensive Cancer Center in OrangePhoto of UC Irvine Health/Chao Family Comprehensive Cancer Center in Orange

Summary

UC Irvine Health/Chao Family Comprehensive Cancer Center is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Ovarian Cancer, Cancer, Lung Cancer, Pancreatic Cancer and other specialties. UC Irvine Health/Chao Family Comprehensive Cancer Center is involved with conducting 519 clinical trials across 519 conditions. There are 47 research doctors associated with this hospital, such as David Hong, MD, Farshid Dayyani, Deepa Jeyakumar, and Ritesh Parajuli, MD.

Area of expertise

1

Breast Cancer

Global Leader

UC Irvine Health/Chao Family Comprehensive Cancer Center has run 67 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive
2

Ovarian Cancer

Global Leader

UC Irvine Health/Chao Family Comprehensive Cancer Center has run 65 trials for Ovarian Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage III

Top PIs

Clinical Trials running at UC Irvine Health/Chao Family Comprehensive Cancer Center

Pancreatic Cancer

Breast Cancer

Cancer

Bladder Cancer

Kidney Cancer

Breast cancer

Colorectal Cancer

Acute Myeloid Leukemia

Ovarian Cancer

Esophageal cancer

Image of trial facility.

Perioperative Chemotherapy

for Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

Recruiting

4 awards

Phase 3

18 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Image of trial facility.

Radiation Therapy

for Cancer with Bone Metastasis

This phase III trial compares the effect of adding radiation therapy to usual care on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms (asymptomatic). High-risk bone metastases are defined by their location (including hip, shoulder, long bones, and certain levels of the spine), or size (2 cm or larger). These bone metastases appear to be at higher risk of complications such as fracture, spinal cord compression, and/or pain warranting surgery or radiation treatment. Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. The total dose of radiation can be delivered in a single day or divided in smaller doses for up to 5 days of total treatment. Usual care for asymptomatic bone metastases may include drugs that prevent bone loss, in addition to the treatment for the primary cancer or observation (which means no treatment until symptoms appear). Evidence has shown that preventative radiation therapy may be effective in lowering the number of bone metastases-related complications, however, it is not known if this approach is superior to usual care. Adding radiation therapy to usual care may be more effective in preventing bone-related complications than usual care alone in cancer patients with asymptomatic high-risk bone metastases.

Recruiting

2 awards

Phase 3

7 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at UC Irvine Health/Chao Family Comprehensive Cancer Center?

Where is UC Irvine Health/Chao Family Comprehensive Cancer Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does UC Irvine Health/Chao Family Comprehensive Cancer Center accept?

What awards or recognition has UC Irvine Health/Chao Family Comprehensive Cancer Center received?